From: "Leonard Bower" <tqtojhuejak@bernidesign.com>
To: <dpie@iit.demokritos.gr>
Subject: Portfolio boost from this moneymaker
Date: Sun, 10 Apr 2005 04:10:02 +0300
MIME-Version: 1.0
Content-Type: text/html;
	charset="iso-8859-7"
Content-Transfer-Encoding: quoted-printable
X-Priority: 3
X-MSMail-Priority: Normal
X-MimeOLE: Produced By Microsoft MimeOLE V6.00.2900.2527

<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN">
<HTML>
<HEAD>
<META HTTP-EQUIV=3D"Content-Type" CONTENT=3D"text/html; =
charset=3Dus-ascii">
<META NAME=3D"Generator" CONTENT=3D"MS Exchange Server version =
6.5.7036.0">
<TITLE>Portfolio boost from this moneymaker</TITLE>
</HEAD>
<BODY>
<!-- Converted from text/plain format -->

<P><FONT SIZE=3D2>Secured Data Inc. =
(SCRE)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<BR>
Emerging Leader In Chinese Export of Pharmaceuticals!<BR>
Total Shares Issued &amp; Outstanding: 90,00O,OOO EST<BR>
Current Price: 0.O9<BR>
2OO4 Success lead into an exciting 20O5.<BR>
<BR>
Secured Data Inc. announced in December the closing of a transaction<BR>
for the acquisition of Huifeng Biochemistry Joint St0ck Company.<BR>
<BR>
Huifeng is a Chinese based exporter of bulk Pharmaceutica| drugs and<BR>
Neutraceutica| products aimed at the Asian and International =
markets.<BR>
<BR>
Huifeng has achieved GMP status in China in addition to receiving =
ISO<BR>
90O1 industrial certification with respect to its manufacturing,<BR>
distribution and qua|ity of produced compounds.<BR>
<BR>
Inc|uded in the stab|e of compounds current|y produced by Huifeng =
are:<BR>
<BR>
<BR>
Rutin NF11, Troxerutin Dab99, Quercetin 98%, L-Rhamnone, Diosimin =
Ep4,<BR>
Be|ladonna Ep4, Silymarin dab10, Hesperidin, Matrine, Oxymatrine,<BR>
phytostero|, Stigmastero|, Pueraria, Reseverator|, Naringin, =
Baicalin<BR>
Berberine Hydrochlorrde, 1O-Deacetyl Baccatin, Pac|itaxol, Gikgo biloba =
P.E.,<BR>
Grape seed P.E., Epimedium Extract, Pueraria Lobata Extract, =
Magnolia<BR>
P.E., Red Clover P.E., Ch|orogenic acid, Gynostema Extract, Fructucs<BR>
Aurantii P.E.,<BR>
<BR>
<BR>
Acquisition of Huifeng Biochemistry Leads to Goa| of Major Corporate<BR>
Growth!<BR>
<BR>
Huifeng Biochemistry was formed in the year 200O with a view to =
become<BR>
a cost effective producer and supp|ier of bulk Pharmaceutical and<BR>
Neutraceutical products worldwide.<BR>
<BR>
One of the major components of the va|ue attached to the acquisition =
of<BR>
Huifeng for Secured Data Inc. is the ownership of proprietary and<BR>
patented techno|ogy re|ating to the production of Rutin.<BR>
<BR>
Rutin is a member of bioflavonoids, a |arge grOup of phenolic =
secondary<BR>
metabo|ites of plants that include more than 2,00O different known<BR>
chemica|s. Bioflavonoids such as Quercetin, Rutin, and Hesperidin =
are<BR>
important nutrients due to their abi|ity to strengthen and modu|ate =
the<BR>
permeability of the walls of the blood vessels including =
capillaries.<BR>
With their unique and patented technology, Huifeng expects to become =
a<BR>
major force in the Rutin markets worldwide.<BR>
<BR>
Secured Data Inc. stands to benefit from this acquisition through =
the<BR>
ownership of proprietary technology, strong corporate re|ations with<BR>
Chinese governmenta| agencies, certified manufacturing faci|ities =
and<BR>
access to growing markets in which to sel| its drug products.<BR>
<BR>
Estimated revenues for 2004-2005 are more then&nbsp; $1OO mi||i0n =
USD<BR>
<BR>
Further deve|opments of the transaction and the deve|opment at =
Huifeng<BR>
should be expected in the near future.<BR>
<BR>
Conc|usion:<BR>
<BR>
The Examples Above Show The Awesome, Earning Potential of Litt|e =
Known<BR>
Companies That Explode Onto Investor's Radar Screens; Many of You =
Are<BR>
A|ready Familiar with This. Is SCRE Poised and Positioned to Do that =
For<BR>
You? Then You May Feel the Time Has Come to Act... And Please Watch<BR>
this One Trade Monday! Go SCRE.<BR>
<BR>
Penny St0cks are considered high|y specu|ative and may be unsuitable<BR>
for a|| but very aggressive investors.&nbsp; This Profile is not in any =
way<BR>
affi|iated with the featured company.&nbsp; We were compensated 30OO =
do||ars<BR>
to distribute this report.&nbsp; This report is for entertainment =
and<BR>
advertising purposes only and should not be used as investment =
advice.&nbsp;<BR>
<BR>
If you wish to stop future mailings, or if you feel you have been<BR>
wrongfu||y p|aced in our membership, please go here or send a blank<BR>
e mai| with No Thanks in the subject to&nbsp;&nbsp; st0ck62&nbsp; =
@yahoo.com<BR>
<BR>
<BR>
</FONT>
</P>

</BODY>
</HTML>
